TrialJournal of the American Heart Association2020

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial.

Eduard Shantsila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.